Biospecimens for Identification of Diseases of the Pancreas.
SPORE-PANC
Biospecimens for the Early Detection, Prevention, Diagnosis and Treatment of Diseases of the Pancreas.
1 other identifier
interventional
712
1 country
1
Brief Summary
This proposed project is designed to collect data and specimens from patients/subjects presenting to the University of Michigan with a disease affecting the pancreas (or specific control populations). This protocol is focused on collecting data, blood samples, and tissue on subjects with pancreatic diseases, including pancreatic cancer, pancreatic cysts, pancreatitis, diabetic controls, jaundice/biliary obstruction controls, and otherwise healthy controls. We are collecting up to 50 mls of blood for research purposes only. Plasma, serum and buffy coat are collected and stored according to strict SOPs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pancreatic-cancer
Started Apr 2011
Longer than P75 for not_applicable pancreatic-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 6, 2011
CompletedFirst Posted
Study publicly available on registry
July 12, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2017
CompletedNovember 8, 2017
November 1, 2017
6.4 years
July 6, 2011
November 6, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validation of glycoprotein panel as a pancreatic cancer biomarker
To create a set of cases and controls to validate a novel glycoprotein panel for non-invasive or early detection of pancreatic cancer.
5 years
Interventions
Blood draw for research specimens only
Eligibility Criteria
You may qualify if:
- Adults 18 years of age or older
- Able to physically tolerate removal of 50 ml of blood
- Willing to sign informed consent.
You may not qualify if:
- Pregnant or lactating
- Known HIV/AIDS or Hepatitis C
- Prepped for colonoscopy at the time of blood collection
- Unable to understand English
- Receiving chemotherapy or radiation at time of enrollment
- Any cancer within 5 years of enrollment except any of the following:
- Squamous cell carcinoma of the skin or Basal cell carcinoma of the skin
- Carcinoma in situ of the cervix, Stages Ia or Ib invasive squamous cell carcinoma of the cervix treated by surgery only. (Excluded if had pelvic radiation)
- Stage Ia Grade 1 adenocarcinoma of the endometrium treated with surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Univerisity of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Project manager
Study Record Dates
First Submitted
July 6, 2011
First Posted
July 12, 2011
Study Start
April 1, 2011
Primary Completion
August 31, 2017
Study Completion
August 31, 2017
Last Updated
November 8, 2017
Record last verified: 2017-11